Can a Compounding Pharmacy Make Your Drug During a Shortage?
Can a compounding pharmacy help during a drug shortage? Your pharmacist says your prescription is on backorder with no date. The FDA shortage list says the drug is in shortage nationally. Between those two facts sits a third option most patients never hear about: a compounding pharmacy can legally make the drug, but only under rules most people get wrong.
The rule that opens the door
Normally, a compounding pharmacy may not prepare a copy of a commercially available drug. If the factory makes it and you can buy it, the compounder cannot just recreate it. That is the "essentially a copy" restriction, and it exists to keep compounding from becoming unregulated manufacturing.
A shortage changes the math. Under section 503A of the Food, Drug, and Cosmetic Act, a drug that appears on the FDA drug shortage list is not treated as commercially available for purposes of the copy restriction. While the listing stands, a prescriber can write for a compounded version, and a state-licensed 503A pharmacy can prepare it. What matters is the specific drug and dosage form on the list, not a general sense that the category is tight. Check the drug shortage tracker to confirm the exact listing before you do anything else.
503A vs 503B: two different kinds of pharmacy
The law recognizes two frameworks. A 503A pharmacy is the traditional compounding pharmacy: state-licensed and compounding patient-specific prescriptions under its state board. A 503B outsourcing facility registers directly with the FDA and may produce larger batches for hospitals and clinics without a patient-specific prescription for each unit.
For a patient, the practical difference is access. Your local 503A pharmacy compounds for you, with your prescription. A 503B facility supplies institutions, so you meet its products at the hospital or clinic, not at the counter. During a shortage, FDA guidance has let both step in: 503A pharmacies may compound shortage-listed copies, and 503B facilities get a 60-day transition period to wind down after a drug leaves the shortage list.
The exception also has a hard edge. FDA keeps a separate list of drugs withdrawn or removed because they were found unsafe or ineffective. Those may not be compounded at all. A drug that left the market for commercial reasons and a drug that left it for safety reasons look identical on a shelf and are treated as opposites in the regulations.
How a compounding pharmacy can help during a drug shortage, in practice
If your medication is on the FDA shortage list, the conversation to have is with your prescriber, not just the pharmacy. The prescriber writes for the compounded version, and can also specify a change that makes a clinical difference for you: a different strength, a liquid instead of a tablet, the removal of an ingredient you react to. That determination is the prescriber's call and has to be documented.
Two things to ask about before you commit. First, price and coverage. Compounded drugs are billed differently, and insurance coverage varies by plan, so get the number before the drug is made. Second, timing. Compounding takes longer than dispensing a bottle off the shelf, and during a real shortage the compounding pharmacies are busy too. It is an option, not a magic door.
There is a bigger version of this story that ran for years. Semaglutide sat on the FDA shortage list from 2022 until February 2025, and tirzepatide until October 2024, and the shortage-list exception is what made large-scale compounding of those GLP-1 drugs lawful the whole time. When the listings ended, the exception closed with them. Same rule, enormous scale.
Frequently asked questions
Is it legal for a pharmacy to copy a drug that is in shortage?
Yes, while the drug appears on the FDA drug shortage list. Normally a 503A pharmacy may not prepare an essential copy of a commercially available drug, but a shortage listing lifts that restriction for the listed drug and dosage form.
What is the difference between 503A and 503B compounding pharmacies?
503A pharmacies are state-licensed and compound patient-specific prescriptions under state board regulation. 503B outsourcing facilities register directly with the FDA and may produce larger batches for hospitals and clinics.
Can a compounding pharmacy make a drug that was pulled for safety reasons?
No. FDA keeps a separate list of drugs withdrawn or removed because they were found unsafe or ineffective, and those may not be compounded at all. A drug discontinued for commercial reasons is treated very differently from one withdrawn for safety.
What happens to compounded copies when the shortage ends?
The exception closes when FDA removes the drug from the shortage list. Best practice for 503A pharmacies is to stop preparing copies immediately; 503B outsourcing facilities get a 60-day transition period to wind down.
Will insurance cover a compounded drug during a shortage?
It varies widely by plan. Many insurers treat compounded medications differently from manufactured drugs, and coverage is not guaranteed. Ask your pharmacist and your plan before you count on reimbursement.
Related reading: Your Prescription Is on Backorder: What to Do Right Now · What to Ask Your Doctor When Your Medication Is in Short Supply · How to Check If Your Drug Is on the FDA Shortage List · How Long Do FDA Drug Shortages Last?